Biotest Aktiengesellschaft Total Liabilities

Latest as of March 2025: €906.90 Million EUR ≈ $1.06 Billion USD

Biotest Aktiengesellschaft total liabilities. Based on the latest financial reports, Biotest Aktiengesellschaft (BIO) has total liabilities worth €906.90 Million EUR (≈ $1.06 Billion USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Biotest Aktiengesellschaft (BIO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Biotest Aktiengesellschaft (2002–2024)

Total liabilities of Biotest Aktiengesellschaft from 2002 to 2024. This chart illustrates how Biotest Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. Explore Biotest Aktiengesellschaft long-term investment intensity to see how much of total assets are deployed in long-term investments.

Biotest Aktiengesellschaft Competitors by Total Liabilities

The table below lists competitors of Biotest Aktiengesellschaft ranked by their total liabilities.

Company	Country	Total Liabilities
Bajaj Mobility AG VI:BMAG	Austria	€1.20 Billion
Guangdong Haomei New Material Co Lt SHE:002988	China	CN¥3.98 Billion
Shanghai Chlor-Alkali Chemical Co Ltd A SHG:600618	China	CN¥4.72 Billion
Far Eastern Department Stores Ltd TW:2903	Taiwan	NT$94.72 Billion
Whitestone REIT NYSE:WSR	USA	$698.32 Million
Brookline Bancorp Inc NASDAQ:BRKL	USA	$10.31 Billion
MoonLake Immunotherapeutics NASDAQ:MLTX	USA	$146.35 Million
Shenzhen Infinova Ltd SHE:002528	China	CN¥1.81 Billion

Liability Composition Analysis (2002–2024)

This chart breaks down Biotest Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BIO asset base.

Liquidity & Leverage Metrics

Biotest Aktiengesellschaft Total Liabilities Ratios Explained

Biotest Aktiengesellschaft total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.64	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotest Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual total liabilities of Biotest Aktiengesellschaft from 2002 to 2024.

Year	Total Liabilities	Change
2024-12-31	€903.30 Million ≈ $1.06 Billion	-0.95%
2023-12-31	€912.00 Million ≈ $1.07 Billion	+9.63%
2022-12-31	€831.90 Million ≈ $972.58 Million	+14.94%
2021-12-31	€723.80 Million ≈ $846.20 Million	+4.94%
2020-12-31	€689.70 Million ≈ $806.33 Million	+9.22%
2019-12-31	€631.50 Million ≈ $738.29 Million	+15.43%
2018-12-31	€547.10 Million ≈ $639.62 Million	-13.26%
2017-12-31	€630.70 Million ≈ $737.35 Million	+10.24%
2016-12-31	€572.10 Million ≈ $668.85 Million	+3.94%
2015-12-31	€550.40 Million ≈ $643.48 Million	-0.36%
2014-12-31	€552.40 Million ≈ $645.81 Million	+29.73%
2013-12-31	€425.80 Million ≈ $497.80 Million	+36.08%
2012-12-31	€312.91 Million ≈ $365.83 Million	-6.90%
2011-12-31	€336.09 Million ≈ $392.93 Million	+3.50%
2010-12-31	€324.73 Million ≈ $379.64 Million	-10.69%
2009-12-31	€363.59 Million ≈ $425.08 Million	+7.36%
2008-12-31	€338.67 Million ≈ $395.94 Million	+8.92%
2007-12-31	€310.94 Million ≈ $363.52 Million	+59.71%
2006-12-31	€194.69 Million ≈ $227.62 Million	-1.73%
2005-12-31	€198.12 Million ≈ $231.63 Million	-20.85%
2004-12-31	€250.31 Million ≈ $292.64 Million	+1.47%
2003-12-31	€246.69 Million ≈ $288.41 Million	-5.55%
2002-12-31	€261.20 Million ≈ $305.37 Million	--

About Biotest Aktiengesellschaft

XETRA:BIO Germany

Market Cap

$976.15 Million

€834.96 Million EUR

Market Cap Rank

#8711 Global

#1144 in Germany

Share Price

€42.20

Change (1 day)

+0.00%

52-Week Range

€42.20 - €42.20

All Time High

€44.10